newsfilter
← Latest News
GlobeNewswire·

Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice

Acquisition adds complementary asset to the Pelthos commercial portfolioXeglyze is a novel, FDA-approved prescription medication indicated for the topical treatment of head lice infestation in patients 6 months of age